PET Scan

A positron emission tomography (PET) scan is a cutting-edge medical imaging technique that visualises and measures the metabolic activity of the body’s tissues and organs. By providing detailed information on the cellular level, positron emission tomography scans have revolutionised the diagnosis, staging, and treatment of numerous diseases, including cancer, neurological disorders, and cardiovascular diseases.

These scans rely on detecting positrons, subatomic particles emitted during the radioactive decay of certain isotopes. The procedure involves the injection of a radiotracer, a compound that includes a small amount of a radioactive substance called a radionuclide. The most commonly used radiotracer is fluorodeoxyglucose (FDG), a molecule similar to glucose. FDG is absorbed by cells throughout the body, with cancerous and other highly active cells taking up more of the compound than normal cells.

As the radionuclide decays, it emits positrons that collide with nearby electrons, resulting in the annihilation of both particles and the production of two gamma-ray photons. These photons travel in opposite directions and are detected by a ring of detectors surrounding the patient. By analysing the timing and location of these detections, a computer can generate a three-dimensional image of the body’s tissues, indicating areas of high and low metabolic activity.

  • PET scans have proven invaluable in oncology, assisting in detecting, staging, and monitoring various cancers. The high metabolic rate of cancer cells enables the PET scan to identify tumours, metastases, and recurrences with remarkable accuracy. Additionally, PET scans can help assess the effectiveness of cancer treatments such as chemotherapy, radiation therapy, and targeted therapies.
  • PET scans have also significantly contributed to the understanding and diagnosing of neurological disorders. By mapping glucose metabolism in the brain, PET scans can detect early signs of Alzheimer’s disease, Parkinson’s disease, and epilepsy. Furthermore, PET scans can be used to localise seizure foci, aiding in the surgical planning for epilepsy patients.
  • In cardiology, PET scans can assess myocardial viability in coronary artery disease or heart failure patients. In addition, by revealing diminished blood flow and metabolic activity areas, PET scans can help identify damaged or non-functioning heart tissue, informing treatment decisions and prognoses.

These scans offer advantages over other imaging techniques, such as computed tomography (CT) and magnetic resonance imaging (MRI). The ability to measure metabolic activity allows for early disease detection and accurate assessment of treatment response. Moreover, these scans can be combined with CT or MRI to provide detailed anatomical and functional information in a single study.

Despite its many benefits, PET scans have limitations. Radioactive tracers may raise concerns about radiation exposure, although the risks are generally low. Additionally, these scans can be costly and not covered by all insurance plans. Finally, PET scans may yield false-positive or false-negative results, particularly in cases of inflammation or infection, which can also demonstrate increased metabolic activity.

You are here:
home » PET scan

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners. View more
Cookies settings
Accept
Decline
Privacy & Cookie policy
Privacy & Cookies policy
Cookie name Active
This privacy and cookies policy sets out how Open Medscience uses and protects any information that you give Open Medscience when you use this website (https://openmedscience.com). Open Medscience is committed to ensuring that your privacy is protected. Should we ask you to provide certain information by which you can be identified when using this website, you can be assured that it will only be used according to this privacy statement. Open Medscience may change this policy from time to time by updating this page. You should check this page from time to time to ensure that you are happy with any changes. This policy is effective from 19 July 2022.

How we use cookies

A cookie is a small file that asks permission to be placed on your computer's hard drive. Once you agree, the file is added and the cookie helps analyse web traffic or lets you know when you visit a particular site. Cookies allow web applications to respond to you as an individual. The web application can tailor its operations to your needs, likes and dislikes by gathering and remembering information about your preferences. We use traffic log cookies to identify which pages are being used. This helps us analyse data about web page traffic and improve our website in order to tailor it to customer needs. We only use this information for statistical analysis purposes and then the data is removed from the system. Overall, cookies help us provide you with a better website, by enabling us to monitor which pages you find useful and which you do not. A cookie in no way gives us access to your computer or any information about you, other than the data you choose to share with us. You can choose to accept or decline cookies. Most web browsers automatically accept cookies, but you can usually modify your browser setting to decline cookies if you prefer. This may prevent you from taking full advantage of the website. Our website (https://openmedscience.com) may contain links to other websites of interest. However, once you have used these links to leave our site, you should note that we do not have any control over that other website. Therefore, we cannot be responsible for the protection and privacy of any information which you provide whilst visiting such sites and such sites are not governed by this privacy statement. You should exercise caution and look at the privacy statement applicable to the website in question. You are here: home » PET scan
Save settings
Cookies settings
Scroll to Top